New Delhi, Dec 9 (PTI) Drug firm Marksans Pharma on Thursday said its subsidiary has received market authorisation from the UK health regulator for its anti-diarrhoea medication Loperamide capsules.
The UK MHRA has granted market authorisation to the company’s wholly-owned subsidiary Relonchem Ltd for Loperamide hard capsules (2mg), Marksans Pharma said in a regulatory filing.
Marksans Pharma said it will manufacture the product at its Goa-based oral dosage facility. PTI MSS BAL BAL
